Publication | Closed Access

Immunogenicity and safety of a two-dose schedule of whole-virion and AS03A-adjuvanted 2009 influenza A (H1N1) vaccines: a randomised, multicentre, age-stratified, head-to-head trial

VaccinationVaccine SafetyTwo-dose ScheduleImmunologyHead-to-head TrialVaccine EfficacyInfluenza VaccineFlu VaccinationInfluenza AMedicineEgg-based Vaccine ProductionInfluenza Vaccines